Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Recurrent WHO Grade 3 Glioma
Salt Lake City, Utah
Recurrent WHO Grade 3 Glioma Clinical Trials in Salt Lake City, Utah
1 recruiting
Salt Lake City, Utah
Showing
1–1
of
1
trials
Recruiting
Phase 2
Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment
Recurrent Glioma
Recurrent WHO Grade 2 Glioma
Recurrent WHO Grade 3 Glioma
+1 more
National Cancer Institute (NCI)
30 enrolled
27 locations
NCT05859334
Feedback